SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Scott, C. K.
Right arrow Articles by Chasin, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Scott, C. K.
Right arrow Articles by Chasin, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Effects of Flunarizine, a New Calcium Antagonist, on Human Red Blood Cells in vitro

Cynthia K. Scott

Department of Biochemical Research, Ortho Pharmaceutical Corporation, Raritan, New Jersey

Francis J. Persico

Department of Biochemical Research, Ortho Pharmaceutical Corporation, Raritan, New Jersey

Karen Carpenter

Department of Biochemical Research, Ortho Pharmaceutical Corporation, Raritan, New Jersey

Mark Chasin

Department of Biochemical Research, Ortho Pharmaceutical Corporation, Raritan, New Jersey

It has been postulated that flunarizine's ability to increase tissue perfusion may be due to either antivasoconstrictor activity, or its effects on red blood cell deformability, or both. In studies reported here, the ability of flunarizine to in fluence human red blood cell membranes has been demonstrated in a number of systems:

(1) Calcium accumulation in the red blood cell is related to a loss of defor mability ; flunarizine inhibited 45Ca accumulation in red blood cells with an IC50 of 46 ± 7 µM. (2) Flunarizine caused a significant increase in deformabi lity, as measured by its ability to decrease ischemia-induced hyperviscosity. (3) Flunarizine had the ability to prevent the discoid-echinocyte transformation in duced by metabolic depletion in ischemic blood as a result of storage. These al terations in red blood cells can all be explained by the localization of one site of action of flunarizine in the membrane of red blood cells, resulting in an inhibi tion of calcium accumulation and maintenance of normal red blood cell defor mability.

Angiology, Vol. 31, No. 5, 320-330 (1980)
DOI: 10.1177/000331978003100503


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
ANGIOLOGYHome page
P. Nihard
Effect of Calcium-Entry-Blockers on Arterioles, Capillaries, and Venules of the Retina
Angiology, January 1, 1982; 33(1): 37 - 45.
[Abstract] [PDF]



Advertisement